For more information on the latest Parkinson’s research, please visit Parkinson’s Europe website.
Scientists develop tomato genetically enriched with Parkinson’s disease drug
Author: Johanna Stiefler JohnsonPublished: 17 December 2020
Prep: Cook: Serves:
Researchers in the UK have succeeded in genetically modifying a tomato with a common Parkinson’s disease drug.
As part of the study, the researchers inserted a gene encoding the enzyme tyrosinase into a tomato to elevate levels of Parkinson’s drug. The aim of this research is to create a more cost-effective production pipeline, wherein Parkinson’s drug is extracted from enriched tomatoes and purified into the pharmaceutical product. Their findings could positively impact people with Parkinson’s who have restricted access to pharmaceutical drugs, providing a more affordable source of the treatment.
Dr Dario Breitel, the research study’s first author, says: “We have demonstrated that the use of tyrosinase-expressing tomatoes as a source of [Parkinson’s drug] is possible. It’s a further demonstration of tomato as a strong option for synthetic biology. Additionally, there were surprising beneficial effects including improvement in shelf-life and raised levels of amino-acids that we can investigate.”
Image credit: Phil Robinson, John Innes Centre.
Find out more about the tomato genetically modified with L-DOPA.
Share this story
Learn coping tricks and strategies for carers at Parkinson’s summit
The Caregiver's Summit aims to equip carers with the tools to take chargeREAD MORE
What to expect: the fourth World Parkinson Congress
We take a look at what you can expect in PortlandREAD MORE
“We can never have enough people helping people with Parkinson’s”
Meet Parkinson’s disease organisations from around the worldREAD MORE